Literature DB >> 16511420

Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe.

Frances F Cowan1, Sophie J S Pascoe, Katrina L Barlow, Lisa F Langhaug, Shabbar Jaffar, John W Hargrove, Noah J Robinson, Ahmed S Latif, Mary T Bassett, David Wilson, David W G Brown, Richard J Hayes.   

Abstract

INTRODUCTION: Herpes simplex virus type 2 (HSV-2) facilitates sexual acquisition of HIV-1 but data on transmission are less clear. In this study the interaction between genital shedding of HIV-1 and HSV-2 was explored among Zimbabwean sex workers.
METHODS: Women (n = 214) were interviewed about genital symptoms. Blood samples were analysed for HIV-1 and HSV-2 antibodies, HIV-1 plasma viral load (PVL) and CD4 lymphocyte count and genital swabs for detection of HIV-1 and HSV-2 genital shedding, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis, and a cervico-vaginal lavage (CVL) for quantitative measurement of HIV-1 shedding. Shedding analyses were undertaken on women co-infected with HSV-2 and HIV-1.
RESULTS: A total of 124 women were co-infected with HIV-1 and HSV-2; 58 were infected with HSV-2 alone. Most HIV-1-infected women were co-infected with HSV-2 (95.4%). Genital HIV-1 shedding was detected in 84.3% of co-infected women and was associated with low CD4 cell count and high PVL but not with reported symptoms of genital herpes or genital shedding of HSV-2. There was no difference in HIV-1 shedding among women shedding HSV-2 (79.3%) and women not shedding HSV-2 (83.2%) (P = 0.64). The adjusted odds ratio for HIV-1 shedding between HSV-2 shedders and non-shedders was 0.8 [95% confidence interval (CI), 0.2-3.3]. HIV-1 PVL(log10) and CVL viral load(log10) were correlated (r = 0.38; 95%CI, 0.2-0.5). After adjusting for PVL, genital symptoms and age, HSV-2 shedding had no effect on CVL viral load (P = 0.13).
CONCLUSION: Rate and quantity of HIV-1 genital shedding do not appear to be altered by presence of HSV-2 genital shedding.

Entities:  

Mesh:

Year:  2006        PMID: 16511420     DOI: 10.1097/01.aids.0000198086.39831.4a

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

Review 1.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

2.  SR-2P vaginal microbicide gel provides protection against herpes simplex virus 2 when administered as a combined prophylactic and postexposure therapeutic.

Authors:  Scott A Fields; Gaurav Bhatia; Julie M Fong; Mingtao Liu; Gita N Shankar
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

Review 3.  Characteristics and quantities of HIV host cells in human genital tract secretions.

Authors:  Joseph A Politch; Jai Marathe; Deborah J Anderson
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

4.  Can we reduce the spread of HIV infection by suppressing herpes simplex virus type 2 infection?

Authors:  Anne Buvé
Journal:  F1000 Med Rep       Date:  2010-06-16

Review 5.  Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention.

Authors:  Aaron Ar Tobian; Thomas C Quinn
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

6.  Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa.

Authors:  Joelle Sobngwi-Tambekou; Dirk Taljaard; Pascale Lissouba; Kevin Zarca; Adrian Puren; Emmanuel Lagarde; Bertram Auvert
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

7.  Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding.

Authors:  Stephen E Hawes; Papa Salif Sow; Joshua E Stern; Cathy W Critchlow; Geoffrey S Gottlieb; Nancy B Kiviat
Journal:  AIDS       Date:  2008-11-30       Impact factor: 4.177

8.  Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa.

Authors:  R G White; E E Freeman; K K Orroth; R Bakker; H A Weiss; N O'Farrell; A Buvé; R J Hayes; J R Glynn
Journal:  Sex Transm Infect       Date:  2008-10       Impact factor: 3.519

9.  Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.

Authors:  Esther E Freeman; Richard G White; Roel Bakker; Kate K Orroth; Helen A Weiss; Anne Buvé; Richard J Hayes; Judith R Glynn
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641

10.  Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.

Authors:  Deborah Watson-Jones; Helen A Weiss; Mary Rusizoka; John Changalucha; Kathy Baisley; Kokugonza Mugeye; Clare Tanton; David Ross; Dean Everett; Tim Clayton; Rebecca Balira; Louise Knight; Ian Hambleton; Jerome Le Goff; Laurent Belec; Richard Hayes
Journal:  N Engl J Med       Date:  2008-03-12       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.